Associated Papers
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.
Anekpuritanang T et al.
Blood Advances, 2021
MPN patients harbor recurrent truncating mutations in transcription factor NF-E2.
Jutzi JS et al.
The Journal of Experimental Medicine, 2013
23589569 (PubMed )
Supplement: supp_jem.20120521_JEM_20120521_sm.pdf
Select a paper to view details